Companies: 10,795·Total market cap: $144.5T
Centogene N.V.

Centogene N.V.

CNTGNASDAQHealthcare
$0.33
+$0.33(+100.00%)
Market Cap$9419082
P/E Ratio
52W High$0.429
52W Low$0.325
Overview

Centogene N.V. (CNTG) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

cntg · pe ratio · data through Dec 31, 2023

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Centogene N.V. (CNTG) measures how much investors pay for each dollar of the company's trailing earnings. CNTG's current PE ratio of N/A is calculated by dividing its stock price of $0.33 by its TTM earnings per share of -$1.26.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31

Forward P/E
N/A
FY2024 est. EPS $-1.02
Based on 1 analyst
EPS (TTM)
-$1.26
TTM · diluted EPS
PEG Ratio
-0.01
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Centogene N.V. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2016 – 2023 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Diagnostics & Research · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Centogene N.V.
Centogene N.V.You
CNTG
$9MN/A-$1.26
Apexigen, Inc.
Apexigen, Inc.
APGN
$10MN/A-$1.59
Channel Therapeutics Corporation
Channel Therapeutics Corporation
CHRO
$9MN/A-$2.30
China Jo-Jo Drugstores, Inc.
China Jo-Jo Drugstores, Inc.
CJJD
$10MN/A-$2.93
ESSA Pharma Inc.
ESSA Pharma Inc.
EPIX
$10MN/A-$0.64
ETAO International Co., Ltd.
ETAO International Co., Ltd.
ETAOF
$0MN/A-$169.64
IMV Inc.
IMV Inc.
IMVIF
$0MN/A-$4.37

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 8 of 8 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2023-12-31Latest
FY2023
$-1.26
2022-12-31
FY2022
$-1.19
2021-12-31
FY2021
$-2.06
2020-12-31
FY2020
$-1.02
2019-12-31
FY2019
$-1.27
2018-12-31
FY2018
$-0.80
2017-12-31
FY2017
$-0.45
2016-12-31
FY2016
$-25.04

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Centogene N.V. (CNTG) measures how much investors pay for each dollar of the company's trailing earnings. CNTG's current PE ratio of N/A is calculated by dividing its stock price of $0.33 by its TTM earnings per share of -$1.26.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.33 ÷ -$1.26 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

CNTG pe ratio · 6 questions

CNTG's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.33 and TTM EPS of -$1.26. Data sourced from Financial Modeling Prep via CNTG's SEC 10-K and 10-Q filings.

CNTG PE ratioWhat is CNTG PE ratioCurrent PE ratio of CNTGCNTG PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Centogene N.V. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09